LENZ

Conviction 0HealthcareScan · Mon, Aug 10, 2026

LENZ$5.36-0.09%

ResistanceSupportVol 14

Vol MA14 800.62K

May 11May 28Jun 16Jul 6Jul 23Aug 10

LENZ Therapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.lenz-tx.com ↗

Price5.36

Change-0.09%

Gap+1.21%

Rel volume0.76×

Avg volume949.8K

Avg $ vol4.96M

SMA 205.28

SMA 505.88

SMA 20013.66

Price vs 50-8.93%

Price vs 200-60.81%

MA stackbearish

50/200 cross—

Supertrenddown · 6.13

RSI (14)47

MACD hist0.05

MACD cross—

Stoch %K / %D36 / 33

ADX (14)16

+DI / −DI21 / 20

RSI divergence—

MACD divergence—

ATR %+6.96%

ADR %6.67%

52w high49.05

52w low4.88

From 52w high-89.08%

Above 52w low+9.73%

New 52w highNo

SqueezeOff

Bollinger width22.09%

%B0.57

Donchian pos46.23%

Donchian high6.14

Donchian low4.68

AVWAP (52w high)16.56

vs AVWAP high-67.66%

AVWAP (52w low)5.26

vs AVWAP low+1.76%

OBV trendFlat

Chaikin MF (20)0.02

Today vs 20d0.76×

Avg vol (14d)800.62K

Avg vol (20d)949.8K

Avg $ vol (20d)4.96M

Market cap167.9M

RS 3m (vs SPY)-50.55%

RS 6m (vs SPY)-75.75%

RS line new highNo

Trend template0/8

Technical rank18.0

1 week+7.21%

1 month-4.20%

3 months-46.77%

6 months-62.34%

1 year-83.33%

YTD-66.53%

P/E-2.04

P/B0.68

P/S8.80

P/FCF-2.40

EPS-2.85

Div yield—

ROE-33.32%

ROA-30.13%

Debt/Eq—

Current10.40

EV/EBITDA-1.58

Gross margin—

Net margin-430.25%

Rev growth—

EPS growth-65.02%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value143.13M

Revenue1.9M

Net income-41.49M

Gross profit—

Free cash flow-70M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out31.35M

Employees152

ListedFri, Mar 22, 2024

Free float18.26M

Float %58.3%

Short interest11.86M

Days to cover10.5d

Short volume38.9%

Squeeze score65 / 100

Next earningsTue, Aug 11, 2026 · after (1d)

EPS forecast−$1.21 · 4 est

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank18.0 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance6.18

Support4.80

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in LENZ

All disclosures →

No recent disclosed trades by Congress in LENZ. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in LENZ

No recent insider (Form 4) filings in LENZ. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in LENZ · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.